Aussie Researcher Urges Ban On Painkillers With Dielofenac As API
This article was originally published in PharmAsia News
Executive Summary
An Australian researcher is calling for a ban on painkillers containing dielofenac, which he said is as dangerous as rofecoxib, the active ingredient in Merck's now-banned Vioxx